Redpin Therapeutics, Inc. — Form D
Redpin Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-09. The offering totals $30.0M, of which $7.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-09
- Form: D
- Accession: 0001735933-20-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $7.8M
- Remaining: $22.2M
- Investors: 8
- Date of first sale: 2020-02-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-362277
Issuer
- Name: Redpin Therapeutics, Inc.
- CIK: 0001735933
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1392 MADISON AVENUE, NEW YORK, NY, 10029
- Phone: 9179719655
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Elma Hawkins | Director | Brooklyn, NY |
| Elma Hawkins | Executive Officer | Brooklyn, NY |
Other filings by this issuer (1)
More